AgeTech Capital

AgeTech Capital is one of the few venture firms in North America to commit explicitly and exclusively to the longevity economy, and it does so from Canada rather than the more obvious west-coast wellness corridor. The firm targets approximately one hundred million dollars in committed capital and invests across longevity, healthtech, caretech, femtech, and aging-in-place technology, treating the aging of the global population as a multi-decade thesis rather than a passing trend. For founders building products and services for older adults, their caregivers, and the systems that support them, AgeTech Capital is one of the most legible early-stage investors in the world.

The thesis takes seriously the demographic reality that the population over sixty-five is the fastest-growing customer segment in most developed economies, and that this segment has been systematically underserved by consumer technology, healthcare delivery, and financial services. AgeTech Capital invests across digital health, tech-enabled care delivery, consumer wellness, and women’s and reproductive health, with the unifying lens being products that improve the quality of life, independence, and care of older adults. The firm is comfortable with both consumer-facing companies that serve seniors and their families directly and enterprise companies that sell into senior living operators, home health agencies, and Medicare Advantage plans. It pays particular attention to companies that combine credible clinical or behavioral evidence with a usable product experience, recognizing that older adults are sophisticated users whose needs are poorly captured by stereotypes.

The input data does not enumerate specific portfolio companies, so founders should request the current portfolio during initial conversations. The publicly observable pattern is a concentration on companies addressing longevity, caregiver support, in-home care technology, senior-friendly digital health, and women’s health across the lifespan. Founders should expect AgeTech to ask detailed questions about how their product is actually used by older adults, what the caregiver experience looks like, and how the company plans to navigate the often-unique reimbursement and procurement dynamics of senior-focused channels.

Check sizes typically fall in the one to five million dollar range at entry, with the firm operating at seed and Series A. AgeTech will participate in the United States as well as Canada, and its mandate explicitly extends across both markets, which makes it a useful partner for founders who want a syndicate with cross-border experience. The firm is willing to lead at seed and to co-lead or follow at Series A, and it tends to deploy reserves into companies that demonstrate strong product-market signal with the older adult population.

Decision-making is centralized in the Canada-based partnership, which is small and operates with the velocity of a focused early-stage fund. Founders should expect engagement from senior partners directly, with conviction forming through a manageable number of substantive conversations. The firm has a thesis-driven culture, and founders who can speak credibly to longevity and aging dynamics will find the conversation moves quickly to substance.

The right approach is a warm introduction from a portfolio founder, a senior care operator, or a co-investor in the longevity space. Cold outreach is read, especially when the founder demonstrates genuine product engagement with older adults rather than a pitch built around generic demographic charts. Founders should arrive with usage data, retention by age cohort, and a clear thesis about how the company will scale within a senior-focused channel.

What founders should know is that AgeTech Capital is a high-signal partner for founders genuinely building for older adults rather than founders who have retrofitted a generic product with a senior marketing veneer. Founders who can articulate why their product matters in the texture of an older adult’s daily life, and who are prepared to engage seriously with the unique commercial dynamics of senior-focused channels, will find AgeTech one of the few firms in North America that is fully aligned with that work.